PeterPhilipReeseMD
Nephrology • Philadelphia, PAAssistant Professor, Medicine, Perelman School of Medicine
Dr. Reese is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
1st Floor, Suite 300 S
Philadelphia, PA 19104Phone+1 215-662-2638Fax+1 215-349-5703
Education & Training
Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2003 - 2005- Brigham and Women's HospitalResidency, Internal Medicine, 1999 - 2002
Johns Hopkins University School of MedicineClass of 1999
Certifications & Licensure
TN State Medical License 2024 - 2026
PA State Medical License 2005 - 2024
MA State Medical License 2002 - 2005- American Board of Internal Medicine Nephrology
Clinical Trials
- Medication Adherence in Kidney Transplant Recipients Using Automated Reminders and Provider Notification Start of enrollment: 2012 Feb 01
- Habit Formation for Adherence to Statin Use and LDL Reduction Start of enrollment: 2013 Jul 01
- Deceased Donor Biomarkers and Recipient Outcomes Start of enrollment: 2010 May 01
- Join now to see all
Publications & Presentations
PubMed
- 254 citationsReconsidering the Consequences of Using Race to Estimate Kidney FunctionNwamaka D. Eneanya, Wei Yang, Peter P. Reese
JAMA. 2019-07-09 - 22 citationsA Roadmap for Innovation to Advance Transplant Access and Outcomes: A Position Statement From the National Kidney Foundation.Krista L. Lentine, Stephen O. Pastan, Sumit Mohan, Peter P. Reese, Alan B. Leichtman
American Journal of Kidney Diseases. 2021-09-01 - 89 citationsAutomated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial.Peter P. Reese, Roy D. Bloom, Jennifer Trofe-Clark, Adam Mussell, Daniel Leidy
American Journal of Kidney Diseases. 2017-03-01
Journal Articles
- Twelve-Month Outcomes After Transplant of Hepatitis C–infected Kidneys into Uninfected Recipients: A Single-Group TrialDavid S Goldberg, Roy D Bloom, Vishnu S Potluri, Susanna M Nazarian, Ali Naji, Emily A Blumberg, Peter L Abt, Peter P Reese, Matthew Levine, Paige Porrett, Melissa Ble..., Annals of Internal Medicine
- Population Level Outcomes and Cost‐Effectiveness of Hepatitis C Treatment Pre Versus Post Kidney TransplantDeirdre Sawinski, Peter P Reese, Margaux Mustian, Jayme E Locke, American journal of transplantation
Authored Content
- New Insights into Optimal Timing of Hepatitis C Virus Treatment for Dialysis Patients Waitlisted for Kidney TransplantJuly 2018
Press Mentions
Unraveling Misinformation About Cancer Clinical TrialsNovember 5th, 2024- HCV-Positive and HCV-Negative Kidney Transplants Have Similar OutcomesNovember 16th, 2022
- Kidney Transplants from Deceased Donors with, Without HCV Yield Similar Graft SurvivalAugust 31st, 2022
- Join now to see all
Grant Support
- Age, Functional Status, And Survival Benefit From Kidney TransplantationNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Measuring Living Kidney Transplantation At Renal Transplant CentersNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
- Predictors Of Living Kidney Donor RecruitmentNational Institute Of Diabetes And Digestive And Kidney Diseases2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
